Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Unknown 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Depression 6Neoplasms 5Anxiety Disorders 5Melanoma 2Depressive Disorder, Major 2Pain 1Osteosarcoma 1Opioid-Related Disorders 1Neoplasm Metastasis 1Lymphoma 1Hospice 1Hematopoietic and Lymphatic System Neoplasm 1Endocrine Gland Neoplasms 1Depressive Disorder 1Caregiver Distress 1Carcinoma, Non-Small-Cell Lung 1Agnosia 1

Interventions

Psilocybin 2Infliximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Depressive Disorder, Major × Psilocybin × Clear all
NCT05947383 2026-05-06

2Dose

Sunstone Medical

Phase 2 Active not recruiting
56 enrolled

Depression, Depressive Disorder, Major, Neoplasms

NCT04593563 2021-10-15

The Safety and Efficacy of Psilocybin in Cancer Patients With Major Depressive Disorder

Maryland Oncology Hematology, PA

Phase 2 Unknown
30 enrolled

Depressive Disorder, Major, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡